Mirae Asset Global Investments Co., Ltd. Beam Therapeutics Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,981 shares of BEAM stock, worth $80,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,981
Previous 2,457
21.33%
Holding current value
$80,665
Previous $57,000
28.07%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BEAM
# of Institutions
230Shares Held
73.3MCall Options Held
283KPut Options Held
233K-
Farallon Capital Management LLC San Francisco, CA7.91MShares$214 Million0.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$214 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$207 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$177 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL5.44MShares$147 Million74.72% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.9B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...